Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 416289, 11 pages
http://dx.doi.org/10.1155/2014/416289
Research Article

Modeling the Differences in Biochemical Capabilities of Pseudomonas Species by Flux Balance Analysis: How Good Are Genome-Scale Metabolic Networks at Predicting the Differences?

Department of Biotechnology, College of Science, University of Tehran, Tehran 1417614411, Iran

Received 31 August 2013; Accepted 24 December 2013; Published 24 February 2014

Academic Editors: P. Giardina and E. Van Heerden

Copyright © 2014 Parizad Babaei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

To date, several genome-scale metabolic networks have been reconstructed. These models cover a wide range of organisms, from bacteria to human. Such models have provided us with a framework for systematic analysis of metabolism. However, little effort has been put towards comparing biochemical capabilities of closely related species using their metabolic models. The accuracy of a model is highly dependent on the reconstruction process, as some errors may be included in the model during reconstruction. In this study, we investigated the ability of three Pseudomonas metabolic models to predict the biochemical differences, namely, iMO1086, iJP962, and iSB1139, which are related to P. aeruginosa PAO1, P. putida KT2440, and P. fluorescens SBW25, respectively. We did a comprehensive literature search for previous works containing biochemically distinguishable traits over these species. Amongst more than 1700 articles, we chose a subset of them which included experimental results suitable for in silico simulation. By simulating the conditions provided in the actual biological experiment, we performed case-dependent tests to compare the in silico results to the biological ones. We found out that iMO1086 and iJP962 were able to predict the experimental data and were much more accurate than iSB1139.

1. Introduction

1.1. Metabolic Networks

Recent advances in sequencing techniques have accelerated the process of whole genome sequencing of different organisms [13]. Additionally, computational tools for genome annotation have improved widely, which leads to better understanding of the function of genomic sequences [4, 5]. With this information in hand and a large amount of data about biochemical pathways accessible in various databases and scientific literature, the opportunity of emergence for the genome-scale metabolic networks has been provided in the last decade [6]. Such metabolic network models provide us with the opportunity to explore the physiological properties of different microorganisms with biotechnological applications [7].

1.2. Reconstruction and Mathematical Modeling of Metabolism

A typical framework for modeling cellular metabolism is constraint-based modeling, which involves stoichiometric and reversibility constraints on reactions [7, 8]. For a particular organism, considering cellular metabolites as the rows and metabolic reactions as the columns of the stoichiometric matrix, a metabolic network model is created in an iterative process. The element of this matrix is the stoichiometric coefficient of metabolite in reaction , considering positive values for products and negative values for reactants. Each (enzymatic) reaction, in turn, is associated with one or a few metabolic genes. In fact, the process of metabolic network reconstruction involves compiling the metabolism of an organism to a machine-readable format. There are various ways to reconstruct a model ranging from bottom up, totally manual approach [9] to the semiautomated process such as rBioNet [10], GEMSiRV [11], and RAVEN [12]. Available genome-scale metabolic network models have a wide spectrum from bacteria [1315], to archaea [16], and to mammals and human [1720].

The common point of the all reconstruction processes is the iterative validation of the model. By performing cycles of in silico experiments and comparing them to the wet-lab results, the discrepancies of the model and the actual organism are recognized. Subsequent model refinements pave the way for having a reliable framework to perform in silico experiments. Such a model allows the researchers for an in-depth and systematic investigation of the cellular metabolism. In the field of genetic engineering [21, 22], drug targeting [2325], and evolutionary studies [2628], models have been very useful so far.

1.3. Goal of the Present Study

Despite the increasing number of available metabolic models, to the best of our knowledge, little effort has been put towards comparing biochemical capabilities of closely related species using their genome-scale metabolic models. Since there is no unique approach to reconstruct a network, the models may contain process-dependent errors (including missing reactions). Therefore, one should not expect the models to reflect the biochemically distinguishable differences as successful as the wet-lab results. Nevertheless, if a model is accurate enough, the in silico results should be close to the real-world data. In this study, we used three Pseudomonas models: iMO1086 for Pseudomonas aeruginosa PAO1 [29, 30], iJP962 for Pseudomonas putida KT2440 [30, 31], and iSB1139 for Pseudomonas fluorescens SBW25 [32] to interrogate the capability of models to reflect biological differences amongst these three Pseudomonas species.

2. Materials and Methods

2.1. Database Search

We decided to compare the models two by two. Considering this, three cases were to be investigated. In first step, we comprehensively searched PubMed database for the entries containing two of the three Pseudomonas species. Primary search results included 675 articles for aeruginosa-putida case, 456 articles for fluorescence-putida case, and 622 articles for aeruginosa-fluorescence case.

The abstracts of these articles were carefully reviewed in order to select the articles of interest. The selected articles in this step were those articles in which biochemically distinguishable differences between the two species were investigated. These articles were reviewed again in detail by reading their full-texts thoroughly, in order to see whether they fulfill the selection criteria (see below).

2.2. Biochemical Properties Which Can Be Verified In Silico

Not every wet-lab experiment is suitable to be simulated in silico. The first criterion is that the particular pathway/gene/enzyme/reaction discussed in the article should be included in the model, as we are not supposed to change the structure of the model. In other words, the goal of this study is to understand the potential of the available genome-scale metabolic networks to model the biochemical differences, not to present improved models. Flux through a reaction and the essentiality of a gene in a specific environmental condition could be tested for the models.

2.2.1. Biochemical Differences

The three Pseudomonas species have a part of their metabolism in common. However, these shared pathways are not exactly the same. For example, the reactions might have different fluxes. On the other hand, some genes or pathways are specific to each of these species. Pathogenesis for P. aeruginosa [33, 34] and catabolic pathways of aromatic compounds for P. putida [35, 36] are the examples of this type of differences. The articles investigating this kind of biochemical differences are suitable for in silico simulation.

2.2.2. Genetic Engineering

Genetic engineering procedures are favorable for in silico simulation. Any changes made in the experiment in order to investigate cellular response to a perturbation should be in the form of adding or removing a particular pathway/gene/enzyme/reaction, or otherwise it could not be tested. Modeling gene and pathway addition or deletion is possible with COBRA toolbox [8, 37] (see below).

2.2.3. Cellular Response Interrogation to Environmental Perturbations

Any metabolic model is a biochemical system with boundaries defined by exchange reactions. These reactions allow the substances to enter or leave the system. Thus, the experiments which have studied the cellular behavior in a particular growth medium or growth conditions could be computationally simulated if the related exchange reactions are included in the model. For instance, the experiments including measuring growth yield on different carbon or nitrogen sources could be simulated by setting the lower and upper bounds of the related exchange reaction to the same constant value. Besides, the upper bound and the lower bound of the other competing exchange reactions should be set to zero. Therefore, no carbon/nitrogen source but the ones provided by the medium could enter the cell. Finally, tolerance to a specific substance is also of interest, since by increasing the related reaction bound and performing FBA, the cellular response to an environmental tension could be simulated and compared to the actual results.

The articles that performed one of the above types of experiments for at least two of the species were ultimately selected to be the reference for our simulations.

2.3. Flux Balance Analysis (FBA)

FBA is a computational method for calculating the flux distribution of a metabolic network under a specified condition [38]. FBA optimizes an objective function (e.g., growth rate) based on the steady-state assumption, which states that the concentration of the cellular metabolites should not vary during the optimization process. This assumption is applied by considering , whereas is the stoichiometric matrix and is the flux distribution vector. Furthermore, each flux distribution is also constrained by the “capacity” of reactions in the form . For example, irreversible reactions can only carry nonnegative flux values; that is, .

As mentioned, in FBA flux through a linear biomass-producing reaction is maximized, based on the evolutionary assumption that a cell tends to maximize its growth. The biomass reaction includes the substrates needed for reproduction with appropriate stoichiometric coefficients, which are based on the ratios of the components forming the cellular dry weight and the energy needed for cellular maintenance (ATP hydrolysis).

2.4. COBRA Toolbox

We used COBRA toolbox to simulate the wet-lab experiment conditions. This toolbox provides us with various functions to perform in silico tests. Firstly, we modeled the experimental conditions, and then FBA was performed to see the model growth yield and flux distribution in the specified conditions.

For genetic engineering experiments, these two functions of the COBRA toolbox were used: “addReaction” and “removeRxns.”(i)“addReaction” receives the chemical equation of the reaction and adds it to the model. If the metabolites are new to the model, they are inserted automatically as a new row to the matrix.(ii)“removeRxns” gets the reaction IDs and deletes them by setting the lower bound and the upper bound of the cited reaction to zero.

In order to simulate the environmental conditions, exchange reaction should be altered manually. The function “changeRxnBounds” was used for this purpose. It can be used to alter either lower or upper bound of a specific reaction.

After modeling the experimental conditions, using COBRA toolbox functions, we ran FBA to see how the model responds and whether it is comparable to the wet-lab results.

3. Results and Discussion

3.1. Growth on Benzene under Different Oxygen Regimes

The growth patterns of the three Pseudomonas species during benzene degradation have been previously investigated under different oxygen regimes, namely, oxic, hypoxic, and anoxic regimes [39]. All of the strains used in the experiment were capable of growing under all oxygen regimes but in a different manner. All strains were inoculated in mineral salt medium containing aqueous benzene. MSM medium contains the following salts: K2HPO4, KH2PO4, (NH4)2SO4, MgCl2, CaCl2, H3BO3, ZnSO4, NiSO4, (NH4)6Mo7O244H2O, CuSO45H2O, MnSO4, CoCl2, and FeCl3.

To define the in silico medium, the “exchange reactions” in iMO1086 and iJP962 and “uptake reactions” in iSB1139 were used. Since not all the ions used in the wet-lab medium were included in the models, it was just possible for the ions which had an associated reaction to enter the model. There was no uptake reaction for benzene in the model. Therefore, we used benzoate as the sole carbon source in our simulations. Benzene and benzoate are both converted to catechol in the cell [40, 41]. Hence, it is reasonable to use benzoate instead of benzene. For carbon source, we set the lower bound and upper bound of all possible carbon source exchange/uptake reactions to zero, except for benzoate. The default maximum flux for the uptake of carbon source for iMO1086 and iJP962 is 10 mmolgDW−1hr−1. We used this upper bound value as a constraint for the all carbon sources used in this study. For simulating oxic, hypoxic, and anoxic conditions, we gradually decreased the maximum possible rate of oxygen uptake. We considered the possible oxygen uptake flux to be greater than 50 mmolgDW−1hr−1 as the oxic, between 10 mmolgDW−1hr−1 and 50 mmolgDW−1hr−1 as hypoxic, and below 10 mmolgDW−1hr−1 as anoxic condition.

Wet-lab experiments [39] showed that P. aeruginosa grew best under oxic conditions and cell growth decreased as the conditions changed from oxic to hypoxic. This decrease continues as the oxygen regime changes from hypoxic to anoxic. Therefore, cell growth is dependent on oxygen availability. Similar to the cell growth, benzene degradation pattern was highly dependent on environmental oxygen. By simulating the carbon source in the medium and oxygen regimes in silico, we ran FBA to see how the model would respond to the above-mentioned conditions. Results are summarized in Figure 1. By lowering the flux of oxygen exchange reaction, biomass production rate and flux through benzene degradation pathway decreased.

fig1
Figure 1: (a) In silico modeling of Pseudomonas species growth on benzoate under different oxygen regimes. In all three cases, biomass production increases as the oxygen uptake flux increases. The same pattern exists in all of the models. However, experimental data suggested different trends of response to the available environmental oxygen. (b) Benzoate uptake flux under different oxygen regimes. Similar to the growth rate, flux of the uptake reaction increases as the available environmental oxygen concentration augments in contrast to the experimental data.

Experimental results for P. putida and P. fluorescens were different from those of P. aeruginosa. The highest cell growth of P. putida and P. fluorescens were achieved under hypoxic and anoxic conditions, respectively. On the other hand, P. putida KT2440, the strain used for computational modeling, is known to be a strict aerobe [42], which is definitely different from the strain used to obtain the experimental data. Thus, we do not expect to see a consistency in this case. Simulating this experiment for iJP962, we got almost the same results as iMO1086. Besides, by performing the in silico experiment of growth on benzene for iSB1139, we obtained qualitatively the same results as the case of P. aeruginosa. This implies that the benzene catabolism between these three models might be the same. We decided to look more carefully into this pathway (see Figure 2). All of the three networks metabolize benzene through the same aerobic process in computational simulations and therefore it is natural to see almost the same results in all three cases. Although wet-lab experiments show different growth patterns, in all of them, biomass and benzene degradation flux were dependent on oxygen regime in a same manner. This might be due to the difference in the strains used in the experiment with the ones for which the models are reconstructed. For example P. putida KT2440 is a strict aerobe [42], whereas the P. putida strain used in the wet-lab experiments grew anaerobically. Another reason is that the benzene degradation pathway used in all of the models is the same and needs oxygen in the first step. Hence, regardless of the different structure of the models, oxygen flux is the determinant factor of benzene degradation pathway flux.

416289.fig.002
Figure 2: Benzoate degradation pathway. As depicted in the map, after benzoate uptake, cytoplasmic benzoate is converted to 1,6-dihydroxy-cis-2,4-cyclohexadiene-1-carboxylic. Since oxygen is one of the reactants, lowering the flux of oxygen uptake would in turn decrease the flux of this reaction, and the whole pathway would be less active, carrying lower flux values. This map shows only a part of metabolism.
3.2. Growth Inhibition by Benzene

It has been shown that high benzene concentration in a growth medium can have toxic effects on the cells. In a wet-lab study, different Pseudomonas species have been grown under high benzene concentrations in MSM medium in order to investigate the tolerance of these species to benzene [43]. Initial inhibition of cell growth occurred in P. putida when aqueous benzene concentration was increased to 200 mg/L, while P. fluorescens stopped growing when benzene concentration approached 300 mg/L. The highest tolerance was 400 mg/L for P. aeruginosa.

By performing in silico simulation of MSM medium with benzoate as the sole carbon source and fixing the oxygen exchange flux rate on 50 mmolgDW−1hr−1, we ran FBA to see how biomass production changes in response to increasing benzoate uptake flux. Results are shown in Figure 3. The biomass flux reached its maximum when benzoate uptake was 11 mmolgDW−1hr−1 for both iMO1086 and iJP962. After the peak, by increasing benzoate uptake flux, biomass flux decreased gradually to zero. The maximum possible flux for benzoate uptake reaction was 24 mmolgDW−1hr−1 for iMO1086 and 23 mmolgDW−1hr−1 for iJP962. For iSB1139, we did not see any decrease in growth rate. The growth rate initially increased as the benzoate uptake flux increased. However, for benzoate uptake fluxes greater than 13.84 mmolgDW−1hr−1, the growth rate reaches the constant value of 1.43 mmolgDW−1hr−1.

416289.fig.003
Figure 3: In silico modeling of Pseudomonas species growth on benzoate in MSM medium with a fixed oxygen uptake flux of 50 mmolgDW−1hr−1. Growth inhibition by high uptake fluxes of benzoate is seen in iMO1086 and iJP962. However, for iSB1139, the growth rate did not decrease, even at high benzene concentrations.

The computational metabolic models of P. aeruginosa and P. putida successfully reproduced the benzene inhibition effect, although they were not successful in explaining the differences in the tolerance levels of the two species. On the other hand, iSB1139 failed to simulate the growth inhibition by high concentration of benzene, which might be due to the “loose” structure of the model, existing internal loops, or exchange reactions which let benzoate or its metabolized forms exit the metabolic system.

3.3. Catabolism of Arginine

There are various pathways in different bacteria which enable them to utilize arginine as the sole source of carbon and nitrogen [44]. A previous study was conducted to determine the relationships between ornithine, citrulline, and arginine utilization pathways in Pseudomonas and related bacteria. The doubling time of the various strains including P. aeruginosa PAO1, P. fluorescens ATCC 13525, and P. putida IRC 204 on minimal medium containing arginine, succinylarginine, ornithine, or citrulline as carbon and nitrogen source has been measured in this study [45].

We used the models of P. aeruginosa, P. fluorescens, and P. putida to predict the biomass production rates in the experimental conditions of the study. For in silico simulation of growth on arginine or succinate or ornithine as the sole source of carbon and nitrogen, we set the flux rate of glucose and ammonium to zero and flux rate of desired metabolite’s uptake/exchange reaction to 10 mmolgDW−1hr−1. Neither Succinylarginine nor citrulline uptake reactions are included in models, nor the catabolic pathways of these compounds. Therefore, these two cases were ruled out in our study. Results are shown in Table 1.

tab1
Table 1: Biological data and in silico results for arginine and succinate utilization of the bacteria and the models. Biological data represent doubling times and in silico results represent computational growth rates.

The cell growth was measured by the doubling time of each strain. Growth rate is associated with the inverse of the doubling time, and therefore we expected to see higher growth rates for shorter doubling times. From the in silico data in all three models, it can be seen that the biomass production rate increases in the cases where the model was allowed to use two carbon sources. When we let succinate and arginine enter the model, we are not able to force the model to use arginine only as the nitrogen source. In all three cases, the models were able to grow on arginine as the sole source of carbon and nitrogen. Allowing the models to use another carbon source like succinate would increase the biomass production rate. The same fact was seen in case of ornithine and succinate. When succinate was used as the carbon and ammonium as the nitrogen source, NH4+ was only the nitrogen source and could not be used as the carbon source as well. Therefore, one should compare the results in a way that the experiments having a single carbon source are compared to each other and not to the ones that have two potential carbon sources.

By comparing the growth rates of iMO1086 and iJP962, we concluded that these two models were almost consistent with experimental data, except for the case of succinate and arginine. In other words, since the doubling time of P. putida is greater than that of P. aeruginosa, one should expect that the growth rate of P. putida is less than P. aeruginosa, which is not the case in the simulations. In case of ornithine as the sole source of carbon and nitrogen, the differences between the doubling times were more than what we observed in the computational results.

For P. fluorescens in all cases, the biomass flux was higher than that of the other two models. This might be because of the “loose” (less-constrained) nature of the iSB1139. Comparison of the results of this model under different conditions could be more reliable. However, by doing so, the growth rate values predicted by the model are far from the experimental data. It suggests that this model needs some refinements and additional constraints, and it may overestimate the biological characteristics.

3.4. D-Fructose Catabolism

To investigate the pathways of D-fructose catabolism in Pseudomonas species, specific activities of the fructose, and succinate catabolism enzymes in cell-free extracts of P. putida, P. fluorescens, and P. aeruginosa, and also the doubling time of these species have been measured. Failure of edd mutant of P. putida in Entner-Doudoroff pathway was also shown, while this mutant strain was able to grow on D-fructose [46].

In the experiment, bacteria were grown on Palleroni-Doudoroff liquid medium [47], containing either D-fructose or succinate. Therefore, in our simulations, we let the model consume ammonium, chloride, magnesium, ferric ion, and citrate which are the components of this medium. In two sets of separate simulations, either fructose or succinate was set as the sole source of carbon and nitrogen. We further simulated the edd mutant by deleting edd gene (PP_1010) from the model. The growth simulations on both fructose and succinate are shown in Table 2.

tab2
Table 2: Growth rates of iMO1086, iJP962, and iSB1139 on fructose and succinate as the sole carbon sources. Biological data represent doubling times and in silico results represent computational growth rates.

Similar to the previous test, succinate could not support biomass production as much as other carbon sources, as in all cases, growth on succinate had the lowest biomass flux. For the growth on D-fructose, iMO1086 and iJP962 were found to be fairly consistent with the wet-lab data. However, difference between the doubling times is much higher than the difference between growth rates. The in silico growth rate of iSB1139 in this case is too high as well and not comparable to the other two models.

The computational model of edd mutant in iJP962 could not reproduce the experimental results. In the wet-lab experiments, this mutation almost doubled the doubling time but did not have any effects on in silico growth. The reaction associated to this gene could not carry any flux during growth on fructose or glucose. Therefore, its removal would not have any effect on the biomass production flux.

3.5. Construction of Nitrate Respiring Pseudomonas putida Kt2440

P. putida is vastly used in biotechnology. However, a major drawback of this strain is its incapability to grow anaerobically. To overcome this disadvantage, a genetically engineered strain was recently constructed by introducing the denitrification pathway of P. aeruginosa [48]. This strain was not able to grow under anoxic conditions, but significant anaerobic survival compared to control strains was observed.

In the experiment, modified M9 medium was used. This medium contained Na2HPO4, KH2PO4, NaCl, NH4Cl, MgSO4, CaCl2, FeSO47H2O, succinate, and pH 6.8 supplemented with either KNO3 or NaNO2. One milliliter trace metal solution was added, which contained ZnSO46H2O, MnCl24H2O, CoSO47H2O, NiCl26H2O, CuCl22H2O, Na2MoO42H2O, and HCl. The exchange reactions of these salts (their related ions) were allowed to carry flux wherever a corresponding exchange reaction was in the model. Although the medium was simulated as much as possible, it could not be simulated precisely.

In silico simulation was performed by knocking in the reactions of denitrification pathway to iJP962. This pathway (Figure 4) begins with an exchange reaction which uptakes nitrate from medium. Then, the pathway continues with reactions that convert this metabolite to gaseous nitrogen (N2), which leaves the system.

416289.fig.004
Figure 4: Denitrification pathway. Metabolites like water, proton, ferricytochrome , ubiquinol, and ubiquinone are excluded for clarity. Dashed line shows the system boundary.

By setting the flux of oxygen uptake reaction to zero and performing FBA, the model was able to have a possible non-zero flux distribution. However, the growth rate was zero in these conditions. Hence, the model did not show any growth in anaerobic conditions, similar to the genetically engineered strain in wet-lab. However, the in silico survival was increased as the network was able to consume nitrate. Thus, the model was able to reproduce the wet-lab results.

Adding new reactions to a model leads to some perturbations in the patterns of flux distributions. However, the denitrification pathway could function independent of the growth (i.e., even when the growth rate is zero), because none of the main metabolites of the pathway had been present in the model.

3.6. Growth on Leucine, Isovalerate, and Succinate

Catabolic pathway of saturated methyl-branched compounds like leucine and isovalerate has been previously investigated in P. aeruginosa and P. putida [49]. The gene products of leucine/isovalerate utilization pathway (Liu) have been studied in detail. The liuRABCDE gene cluster is essential for leucine/isovalerate utilization in P. aeruginosa. It is indicated that both species are able to grow on leucine or isovalerate as the sole carbon source. Both P. aeruginosa and P. putida grew well on isovalerate, while growth on leucine was more favorable for P. putida in comparison to P. aeruginosa. In silico result was able to predict this phenomenon, as the flux through biomass reaction of iJP962 was higher (although marginally) than that of iMO1086 (see below).

In this study, mineral salt medium was used with leucine or isovalerate as the sole carbon source. The components of this medium and in silico simulation of MSM are mentioned previously in the text. Here, for simulating growth on leucine/isovalerate, we set the lower bound and upper bound of the all exchange reactions of the all possible carbon sources to zero, except for leucine or isovalerate uptake reaction. According to the experimental results, P. putida could grow better than P. aeruginosa on leucine. They had the same growth pattern on isovalerate as the sole carbon source. Since the difference was related to growth on leucine, we simulated growth on this carbon source. In silico results were consistent with experimental data; that is, the growth rates of iJP962 and iMO1086 were 0.785 and 0.778 mmolgDW−1hr−1, respectively.

In the above-mentioned experimental study [49], some mutations were made in order to determine the essentiality of each gene product in the pathway in P. aeruginosa. It appeared that by making insertion mutations in liuC and liuD genes, the mutants lost their ability to grow on leucine. Inactivation of liuC gene in iMO1086 had no effect on in silico growth, while removing the liuD gene led to zero flux in biomass production. We investigated the reason of this discrepancy and found out that the Liu pathway of the model was different from the one described in the experiment. Figure 5 depicts a part of leucine metabolism. The pathway, which goes via 3-methylbutanoyl-CoA is included in the model, and the alternative which goes via 3-Hydroxyisovaleryl-CoA is the one suggested previously [49]. Reaction C′, which is related to liuC, is not utilized by the model. We added the reaction B′ to the model, upstream to C′, in order to complete the suggested pathway by the reference. The model did not include this reaction, although adding the new reaction did not change the preference of the model to carry flux through the pathway which goes via 3-methylbutanoyl-CoA. However, reaction D is associated with liuD. Since during growth on leucine, this reaction is active, its deletion led to zero growth rate. The strain used in this experiment and the strain which model is built for are the same (i.e., both are P. aeruginosa PAO1), and therefore the discrepancy could not be related to difference in the strains. We propose that such an inconsistency is presumably due to little or no flux in reactions B′ and C′ (if it is not an error in the reconstruction procedure and the bioinformatics data).

416289.fig.005
Figure 5: Leucine degradation pathway. The path in which the arrows are green is present in the model, while the path which includes 3-hydroxyisovaleryl-CoA is suggested by the experimental data.
3.7. Utilization of L-Amino Acids as the Sole Source of Carbon and Nitrogen

According to several reports, amino acid metabolism might occur in bacteria under nutritionally poor conditions. Amino acids can serve as the sole source of carbon and nitrogen in complete absence of organic growth factors, and this physiological property is vastly seen amongst bacteria [5052]. An experiment has been previously conducted to analyze the cell growth of two Pseudomonas species, namely, P. fluorescens and P. aeruginosa on single L-amino acids as sole source of carbon and nitrogen [53].

Lochhead-Chase basal medium [54] has been used with the modification that glucose and nitrate had been replaced by a single amino acid as both carbon and nitrogen source. Besides amino acids, this medium contained mineral salts. Since we could not determine the exact components of this medium, we performed the simulations in MSM medium which was also constituted of mineral salts. For making an amino acid, the sole source of carbon and nitrogen, we set the upper bound and lower bound of the exchange/uptake reaction all of the carbon and nitrogen sources to zero.

In the wet-lab experiment, the ability of growth on all twenty amino acids in the “L” form as the sole source of carbon and nitrogen was investigated. The results had been estimated visually and on a scale from 0 to 2, 0 meaning no growth and 2 meaning good growth. They also used 1 for poor growth. Seventeen of the amino acids produced almost the same growth response. Only L-threonine, L-tryptophan, and L-hydroxyproline had different effects on the cell growth pattern. Therefore, these data could be subject to our study since they reflect the biochemical differences.

We simulated the experiment in silico and performed FBA to see the biomass reaction flux and compare it to wet-lab results. In silico results are shown in Table 3. In the case of L-hydroxyproline, there was no uptake reaction in either of the models; hence, we could not perform FBA. We could add an exchange reaction to the model, keeping in mind that the consumed metabolite should be metabolized and a single uptake reaction may not be sufficient. Since the catabolic pathway of L-hydroxyproline is not included in the models, we did not perform the growth simulation on L-hydroxyproline.

tab3
Table 3: Relative cell growth estimated visually from amount of growth on amino acid.

For the case of L-threonine and L-tryptophan, computational results were not completely consistent with the wet-lab data. In iMO1086, cell growth occurred on L-threonine. In silico simulation in this case produced the same results. The model, however, was not able to grow on L-tryptophan in contrast to the wet-lab data. This inconsistency might be because of difference in the strain used in the experimental study or an error of the model.

In case of the iSB1139 model, growth on L-threonine was found to be possible. However, model could not produce any biomass on L-tryptophan. This could be due to the difference of experimental and in silico strains or missing pathways in the model.

3.8. Histidine Utilization By Pseudomonas Species

Amino acids like histidine are important sources of carbon, nitrogen, and energy for Pseudomonas species. Histidine degradation in bacteria occurs via either a four-step or a five-step enzymatic pathway [55]. Pseudomonas fluorescens SBW25 degrades histidine by the five-step pathway [56]. On the other hand, Pseudomonas aeruginosa PAO1 utilizes this amino acid through both four- and five-step pathways. Studies have shown that this bacterium does not necessarily use both routes at the same time and it can interchange the routes depending on the environment [57].

We assumed that by knocking out the five-step pathway in both species, P. aeruginosa would be able to grow on histidine, as it has the alternative histidine utilization pathway. However, the inactivation of the five-step pathway of P. fluorescens would lead to cell death on histidine, since the only catabolic pathway of this amino acid would be inactivated.

We simulated the minimal M9 medium conditions for both iMO1086 and iSB1139. For this purpose, we set the exchange reaction flux of glucose and ammonia to zero and instead we set the uptake rate of histidine to 10 mmolgDW−1hr−1.

As shown in Figure 6, the three first reactions are shared between these two pathways;  by blocking either hutF or hutG, the five-step pathway would be blocked. We simulated inactivation of the five-step pathway by inactivating hutG gene or its associated reaction. By deleting this gene, flux through this pathway did not change, as there was another gene associated with the reaction with “OR.” When we removed the reaction associated with hutG, the model could not grow on histidine. We investigated the reason of this inconsistency and we found out that only the five-step pathway of histidine utilization is included in iMO1086. Therefore, by deactivating the pathway, the model could not simulate the growth on histidine.

416289.fig.006
Figure 6: Histidine utilization pathway in P. aeruginosa. This strain can metabolize histidine either through a four-step or a five-step pathway. P. fluorescens is only capable of utilizing histidine through the five-step pathway.

It should be noted that the model of P. fluorescens, that is, iSB1139, showed no growth on histidine as the sole source of carbon and nitrogen. These results are against the biological observations [56], which means that the model is presumably incomplete (if the disagreement is not related to the strain differences).

3.9. Amino Acid Utilization in P. putida versus P. fluorescens

Utilization of acidic amino acids and their amides as the sole source of carbon and nitrogen by Pseudomonas species has been investigated previously [58], and the growth profiles of P. putida and P. fluorescens have been studied qualitatively (Table 4). It has been shown that an enzyme involved in glutamate and aspartate utilization, called periplasmic glutaminase/asparaginase (PGA), is induced by glutamate and related amino acids. PGA is the product of ansB gene. It has also been shown that a mutant of P. putida KT2440 in ansB gene was not able to utilize glutamine, while growth on other amino acids was possible [58].

tab4
Table 4: Qualitative growth profiles of P. putida and P. fluorescens on three amino acids. Relative growth rates were estimated qualitatively.

In the experiment, that is, growth on amino acids as the sole source of carbon and nitrogen, bacteria were grown on M9 minimal medium with amino acid as the sole source of carbon and nitrogen.

We have simulated the experimental conditions in silico by making the desired amino acid as the sole source of carbon and nitrogen and setting the upper and lower bound of the exchange/uptake reactions of all other possible carbon and nitrogen sources to zero.

Results of amino acid consumption are shown in Table 4. For P. putida, experimental and computational data were almost consistent. The only case of inconsistency was related to leucine in which no growth was seen in the wet-lab experiment, while the model produced a considerable flux rate of biomass production. Since the strain used in the experiment and in silico simulation was the same, this inconsistency might be due to falsely added reactions in the model.

For the model of P. fluorescens, there are several inconsistencies for cysteine, serine, glutamine, and glutamate. However, in this case, the strain used in the experiment (ATCC 13525) was different from the modeled strain (SBW25), which may (or may not) be the source of inconsistencies.

The lethal effect of ansB deletion for growth on glutamine has been indicated in this study. The product of this gene, PGA, is a periplasmic enzyme that converts glutamine to glutamate. Mutant cells lacking this enzyme were unable to grow on glutamine and concentration of glutamine in the medium did not decrease over time. Therefore, mutant cells were unable to uptake this amino acid. However, they could grow on glutamate and other amino acids [58].

By simulating experimental conditions, we performed gene essentiality analysis. Deleting ansB gene (PP0495) or removing its associated reaction had no effect on model growth. The reason of the inconsistency is that there are alternative pathways included in the model for converting glutamine to glutamate and hence these reactions performed the conversion in the absence of ansB product.

4. Concluding Remarks

To date, several genome-scale metabolic networks have been reconstructed. These models have been used for different purposes, ranging from basic science studies to metabolic engineering applications. However, to the best of our knowledge, using these models in a comparative manner has not attracted much attention previously.

In this study, we used three Pseudomonas metabolic network models in a series of in silico comparative simulations and then evaluated the computational results with the experimental data. It should be emphasized that for gathering information, we used the previously reported experimental data on the same species, but we did not limit our search necessarily to the strains for which the models were built. A number of studies have previously applied such a strategy for validating reconstructed metabolic network models [5961]. However, this might lead to inconsistencies between experimental and computational results, as various strains of the same species have different biochemical properties. We encountered such a case in our study, namely, for the aerobic growth of P. putida on benzene (Section 3.1).

In our study, in most of the cases, P. aeruginosa and P. putida models could reproduce previously reported experimental results. However, the model for P. fluorescens failed to predict the biological data in several instances. One reason for high accuracy of iMO1086 and iJP962 is the vast availability of biological data for P. aeruginosa and P. putida. Since P. aeruginosa is an opportunistic human pathogen [33, 34] and P. putida is a bacterium of biotechnological importance [31, 48], the models of these strains include enough data after iterative refinement of the reconstruction process. Moreover, these two models have been further validated during a process called “reconciliation” [30], which includes comparing metabolic network models to eliminate errors that have been included in the model during the reconstruction.

The very recent in silico model of P. fluorescens, iSB1139, showed inconsistent results with experimental data in many of our simulations. It is known that the computational growth rate of this model is far from the reported experimental growth rate [32]. According to our results, this model needs further refinement in order to produce more reliable predictions.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

  1. M. Ronaghi, “Pyrosequencing sheds light on DNA sequencing,” Genome Research, vol. 11, no. 1, pp. 3–11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Shendure and H. Ji, “Next-generation DNA sequencing,” Nature Biotechnology, vol. 26, no. 10, pp. 1135–1145, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. B. M. Venkatesan and R. Bashir, “Nanopore sensors for nucleic acid analysis,” Nature Nanotechnology, vol. 6, no. 10, pp. 615–624, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Beckloff, S. Starkenburg, T. Freitas, and P. Chain, “Bacterial genome annotation,” Methods in Molecular Biology, vol. 881, pp. 471–503, 2012. View at Google Scholar
  5. X. Mao, T. Cai, J. G. Olyarchuk, and L. Wei, “Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary,” Bioinformatics, vol. 21, no. 19, pp. 3787–3793, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. A. M. Feist, M. J. Herrgård, I. Thiele, J. L. Reed, and B. Ø. Palsson, “Reconstruction of biochemical networks in microorganisms,” Nature Reviews Microbiology, vol. 7, no. 2, pp. 129–143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. R. Zomorrodi, P. F. Suthers, S. Ranganathan, and C. D. Maranas, “Mathematical optimization applications in metabolic networks,” Metabolic Engineering, vol. 14, pp. 672–686, 2012. View at Google Scholar
  8. J. Schellenberger, R. Que, R. M. T. Fleming et al., “Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0,” Nature Protocols, vol. 6, no. 9, pp. 1290–1307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Thiele and B. Ø. Palsson, “A protocol for generating a high-quality genome-scale metabolic reconstruction,” Nature Protocols, vol. 5, no. 1, pp. 93–121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. S. G. Thorleifsson and I. Thiele, “rBioNet: a COBRA toolbox extension for reconstructing high-quality biochemical networks,” Bioinformatics, vol. 27, no. 14, Article ID btr308, pp. 2009–2010, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. C. Liao, M. H. Tsai, F. C. Chen, and C. A. Hsiung, “GEMSiRV: a software platform for GEnome-scale metabolic model simulation, reconstruction and visualization,” Bioinformatics, vol. 28, pp. 1752–1758, 2012. View at Google Scholar
  12. R. Agren, L. Liu, S. Shoaie, W. Vongsangnak, I. Nookaew, and J. Nielsen, “The RAVEN toolbox and its use for generating a genome-scale metabolic model for Penicillium chrysogenum,” PLoS Computational Biology, vol. 9, Article ID e1002980, 2013. View at Google Scholar
  13. A. M. Feist, C. S. Henry, J. L. Reed et al., “A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information,” Molecular Systems Biology, vol. 3, article 121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Heinemann, A. Kümmel, R. Ruinatscha, and S. Panke, “In silico genome-scale reconstruction and validation of the Staphylococcus aureus metabolic network,” Biotechnology and Bioengineering, vol. 92, no. 7, pp. 850–864, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. C. H. Schilling, M. W. Covert, I. Famili, G. M. Church, J. S. Edwards, and B. O. Palsson, “Genome-scale metabolic model of Helicobacter pylori 26695,” Journal of Bacteriology, vol. 184, no. 16, pp. 4582–4593, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. A. M. Feist, J. C. M. Scholten, B. Ø. Palsson, F. J. Brockman, and T. Ideker, “Modeling methanogenesis with a genome-scale metabolic reconstruction of Methanosarcina barkeri,” Molecular Systems Biology, vol. 2, Article ID 2006.0004, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. N. C. Duarte, S. A. Becker, N. Jamshidi et al., “Global reconstruction of the human metabolic network based on genomic and bibliomic data,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 6, pp. 1777–1782, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. L. K. Nielsen, “On the reconstruction of the Mus musculus genome-scale metabolic network model,” in Genome Informatics, p. 253, World Scientific, 2008. View at Google Scholar
  19. S. Selvarasu, I. A. Karimi, G.-H. Ghim, and D.-Y. Lee, “Genome-scale modeling and in silico analysis of mouse cell metabolic network,” Molecular BioSystems, vol. 6, no. 1, pp. 152–161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. I. Sigurdsson, N. Jamshidi, E. Steingrimsson, I. Thiele, and B. T. Palsson, “A detailed genome-wide reconstruction of mouse metabolism based on human Recon 1,” BMC Systems Biology, vol. 4, article 140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Pharkya, A. P. Burgard, and C. D. Maranas, “OptStrain: a computational framework for redesign of microbial production systems,” Genome Research, vol. 14, no. 11, pp. 2367–2376, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Pharkya, A. P. Burgard, and C. D. Maranas, “Exploring the overproduction of amino acids using the bilevel optimization framework optknock,” Biotechnology and Bioengineering, vol. 84, no. 7, pp. 887–899, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. O. Folger, L. Jerby, C. Frezza, E. Gottlieb, E. Ruppin, and T. Shlomi, “Predicting selective drug targets in cancer through metabolic networks,” Molecular Systems Biology, vol. 7, article 501, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. U. Kim, S. B. Sohn, and S. Y. Lee, “Metabolic network modeling and simulation for drug targeting and discovery,” Biotechnology Journal, vol. 7, no. 3, pp. 330–342, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Perumal, A. Samal, K. R. Sakharkar, and M. K. Sakharkar, “Targeting multiple targets in Pseudomonas aeruginosa PAO1 using flux balance analysis of a reconstructed genome-scale metabolic network,” Journal of Drug Targeting, vol. 19, no. 1, pp. 1–13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. M. Feist and B. Ø. Palsson, “The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli,” Nature Biotechnology, vol. 26, no. 6, pp. 659–667, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Pál, B. Papp, and M. J. Lercher, “Adaptive evolution of bacterial metabolic networks by horizontal gene transfer,” Nature Genetics, vol. 37, no. 12, pp. 1372–1375, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Pál, B. Papp, M. J. Lercher, P. Csermely, S. G. Oliver, and L. D. Hurst, “Chance and necessity in the evolution of minimal metabolic networks,” Nature, vol. 440, no. 7084, pp. 667–670, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Oberhardt, J. Puchałka, K. E. Fryer, V. A. P. Martins Dos Santos, and J. A. Papin, “Genome-scale metabolic network analysis of the opportunistic pathogen Pseudomonas aeruginosa PAO1,” Journal of Bacteriology, vol. 190, no. 8, pp. 2790–2803, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M. A. Oberhardt, J. Puchałka, V. A. P. M. dos Santos, and J. A. Papin, “Reconciliation of genome-scale metabolic reconstructions for comparative systems analysis,” PLoS Computational Biology, vol. 7, no. 3, Article ID e1001116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Puchałka, M. A. Oberhardt, M. Godinho et al., “Genome-scale reconstruction and analysis of the Pseudomonas putida KT2440 metabolic network facilitates applications in biotechnology,” PLoS Computational Biology, vol. 4, no. 10, Article ID e1000210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. S. E. Borgos, S. Bordel, H. Sletta et al., “Mapping global effects of the anti-sigma factor MucA in Pseudomonas fluorescens SBW25 through genome-scale metabolic modeling,” BMC Systems Biology, vol. 7, p. 19, 2013. View at Google Scholar
  33. E. E. Smith, D. G. Buckley, Z. Wu et al., “Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 22, pp. 8487–8492, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Zhang, H. Li, J. Wang, Z. Dong, S. Mian, and F.-S. X. Yu, “Role of EGFR transactivation in preventing apoptosis in Pseudomonas aeruginosa-infected human corneal epithelial cells,” Investigative Ophthalmology and Visual Science, vol. 45, no. 8, pp. 2569–2576, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. J. I. Jiménez, B. Miñambres, J. L. García, and E. Díaz, “Genomic analysis of the aromatic catabolic pathways from Pseudomonas putida KT2440,” Environmental Microbiology, vol. 4, no. 12, pp. 824–841, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. M. J. Worsey and A. P. Williams, “Metablism of toluene and xylenes by Pseudomonas putida (arvilla) mt 2: evidence for a new function of the TOL plasmid,” Journal of Bacteriology, vol. 124, no. 1, pp. 7–13, 1975. View at Google Scholar · View at Scopus
  37. S. A. Becker, A. M. Feist, M. L. Mo, G. Hannum, B. Ø. Palsson, and M. J. Herrgard, “Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox,” Nature Protocols, vol. 2, no. 3, pp. 727–738, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. J. D. Orth, I. Thiele, and B. O. Palsson, “What is flux balance analysis?” Nature Biotechnology, vol. 28, no. 3, pp. 245–248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Mahendran, N.-C. Choi, J.-W. Choi, and D.-J. Kim, “Effect of dissolved oxygen regime on growth dynamics of Pseudomonas spp during benzene degradation,” Applied Microbiology and Biotechnology, vol. 71, no. 3, pp. 350–354, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Nakazawa and T. Yokota, “Benzoate metabolism in Pseudomonas putida(arvilla) mt 2: demonstration of two benzoate pathways,” Journal of Bacteriology, vol. 115, no. 1, pp. 262–267, 1973. View at Google Scholar · View at Scopus
  41. C. Bagnéris, R. Cammack, and J. R. Mason, “Subtle difference between benzene and toluene dioxygenases of Pseudomonas putida,” Applied and Environmental Microbiology, vol. 71, no. 3, pp. 1570–1580, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. V. A. P. Martins Dos Santos, S. Heim, E. R. B. Moore, M. Strätz, and K. N. Timmis, “Insights into the genomic basis of niche specificity of Pseudomonas putida KT2440,” Environmental Microbiology, vol. 6, no. 12, pp. 1264–1286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. D.-J. Kim, J.-W. Choi, N.-C. Choi, B. Mahendran, and C.-E. Lee, “Modeling of growth kinetics for Pseudomonas spp. during benzene degradation,” Applied Microbiology and Biotechnology, vol. 69, no. 4, pp. 456–462, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Cunin, N. Glansdorff, A. Pierard, and V. Stalon, “Biosynthesis and metabolism of arginine in bacteria,” Microbiological Reviews, vol. 50, no. 3, pp. 314–352, 1986. View at Google Scholar · View at Scopus
  45. V. Stalon, C. Vander Wauven, P. Momin, and C. Legrain, “Catabolism of arginine, citrulline and ornithine by Pseudomonas and related bacteria,” Journal of General Microbiology, vol. 133, pp. 2487–2495, 1987. View at Google Scholar · View at Scopus
  46. M. H. Sawyer, P. Baumann, and L. Baumann, “Pathways of D fructose catabolism in species of Pseudomonas,” Archives of Microbiology, vol. 112, no. 1, pp. 49–55, 1977. View at Google Scholar · View at Scopus
  47. N. Palleroni and M. Doudoroff, “Some properties and taxonomic sub-divisions of the genus Pseudomonas,” Annual Review of Phytopathology, vol. 10, pp. 73–100, 1972. View at Google Scholar
  48. A. Steen, F. Ö. Utkür, J. M. Borrero-de Acuña et al., “Construction and characterization of nitrate and nitrite respiring Pseudomonas putida KT2440 strains for anoxic biotechnical applications,” ,Journal of Biotechnology, vol. 163, pp. 155–165, 2013. View at Google Scholar
  49. K. Förster-Fromme, B. Höschle, C. Mack, M. Bott, W. Armbruster, and D. Jendrossek, “Identification of genes and proteins necessary for catabolism of acyclic terpenes and leucine/isovalerate in Pseudomonas aeruginosa,” Applied and Environmental Microbiology, vol. 72, no. 7, pp. 4819–4828, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. P. M. Bapat, D. Das, S. V. Sohoni, and P. P. Wangikar, “Hierarchical amino acid utilization and its influence on fermentation dynamics: rifamycin B fermentation using Amycolatopsis mediterranei S699, a case study,” Microbial Cell Factories, vol. 5, article 32, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. S. A. Macko, M. L. Fogel, P. E. Hare, and T. C. Hoering, “Isotopic fractionation of nitrogen and carbon in the synthesis of amino acids by microorganisms,” Chemical Geology, vol. 65, no. 1, pp. 79–92, 1987. View at Google Scholar · View at Scopus
  52. L. M. Li, H. Diao, X. L. Ding, K. Qian, and Z. J. Yin, “Effects of methionine or Lysine served as sole Nitrogen and Carbon sources on level of free amino acids and activity of transaminases at in vitro incubation of rumen microorganisms,” Journal of Animal and Veterinary Advances, vol. 10, no. 12, pp. 1588–1591, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Halvorson, “Utilization of single L-amino acids as sole source of carbon and nitrogen by bacteria,” Canadian Journal of Microbiology, vol. 18, no. 11, pp. 1647–1650, 1972. View at Google Scholar · View at Scopus
  54. A. G. Lochhead and F. E. Chase, “Qualitative studies of soil microorganisms: V. Nutritional requirements of the predominant bacterial flora,” Soil Science, vol. 55, pp. 185–196, 1943. View at Google Scholar
  55. J. G. Coote and H. Hassall, “The degradation of L-histidine, imidazolyl-L-lactate and imidazolylpropionate by Pseudomonas testosteroni,” Biochemical Journal, vol. 132, no. 3, pp. 409–422, 1973. View at Google Scholar · View at Scopus
  56. X.-X. Zhang and P. B. Rainey, “Genetic analysis of the histidine utilization (hut) genes in Pseudomonas fluorescens SBW25,” Genetics, vol. 176, no. 4, pp. 2165–2176, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. M. L. Gerth, M. P. Ferla, and P. B. Rainey, “The origin and ecological significance of multiple branches for histidine utilization in Pseudomonas aeruginosa PAO1,” Environmental Microbiology, vol. 14, no. 8, pp. 1929–1940, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Sonawane, U. Klöppner, C. Derst, and K.-H. Röhm, “Utilization of acidic amino acids and their amides by pseudomonads: role of periplasmic glutaminase-asparaginase,” Archives of Microbiology, vol. 179, no. 3, pp. 151–159, 2003. View at Google Scholar · View at Scopus
  59. K. R. Kjeldsen and J. Nielsen, “In silico genome-scale reconstruction and validation of the Corynebacterium glutamicum metabolic network,” Biotechnology and Bioengineering, vol. 102, no. 2, pp. 583–597, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. W. Zou, M. Zhou, L. Liu, and J. Chen, “Reconstruction and analysis of the industrial strain Bacillus megaterium WSH002 genome-scale in silico metabolic model,” Journal of Biotechnology, vol. 164, pp. 503–509, 2013. View at Google Scholar
  61. Y.-K. Oh, B. O. Palsson, S. M. Park, C. H. Schilling, and R. Mahadevan, “Genome-scale reconstruction of metabolic network in Bacillus subtilis based on high-throughput phenotyping and gene essentiality data,” Journal of Biological Chemistry, vol. 282, no. 39, pp. 28791–28799, 2007. View at Publisher · View at Google Scholar · View at Scopus